Singapore’s Vape Crackdown - Prohibition, Punishment, and Moral Panic

Singapore is being held up as a model for the future of tobacco and drug control. A “turning point,” according to the World Health Organisation. A country brave enough to do what others supposedly lack the courage to do: ban first, punish hard, and ask questions later. Hotlines to report vapers. Random bag searches. Mandatory rehabilitation. Caning. Deportation. All justified in the name of public health.

But strip away the choreography of enforcement and the breathless praise, and what Singapore is really demonstrating is something far less admirable: how prohibition creates the very harms it later uses to justify itself.

Vaping was banned in Singapore in 2018, not because it had caused widespread harm, but because authorities decided it might. It was framed as a precaution, an act of foresight. What followed was entirely predictable to anyone familiar with the history of prohibition. A thriving underground market emerged, operating online, through chat apps and informal networks. With no legal consumer products, no quality standards, and no accountability, the black market did what black markets always do: it innovated toward potency, addiction, and profit.

Enter K-pods drug-laced vapes containing etomidate. These were not an accident of regulation. They were a direct consequence of the ban itself. When you outlaw a relatively low-risk consumer product, you do not eliminate demand; you distort supply. You push sellers toward higher-margin, higher-risk goods that justify the danger of trafficking. This is not a vaping story. It is an alcohol prohibition story. A war-on-drugs story. A story we have seen repeatedly, and always with the same ending.

Instead of acknowledging this causal chain, Singapore’s government collapsed all vaping into a single category of threat. The delivery device became the enemy. The adult smoker who switched to a nicotine vape was treated the same as a trafficker selling anaesthetic-laced pods. The response was not targeted enforcement against drug adulteration, but collective punishment: harsher laws, broader surveillance, and ever more severe penalties for everyone.

Caning someone for possessing an e-cigarette is not public health. It is a spectacle. It is the state asserting moral authority through pain rather than evidence. When schools are authorised to cane students for vaping, the boundary between health policy and corporal discipline collapses entirely. This is not about reducing harm. It is about enforcing obedience.

Supporters of Singapore’s approach argue that an outright ban has “contained the problem.” But contained compared to what? Compared to a hypothetical future where vaping becomes “entrenched” like smoking? That argument assumes its conclusion. It ignores the observable trade-off now occurring: adult vapers returning to cigarettes because the lower-risk alternative has been criminalised. One interviewee in the BBC piece says this plainly. He is switching back to smoking a product that Singapore continues to sell legally, tax heavily, and profit from.

This contradiction sits at the heart of Singapore’s policy and is never resolved. Cigarettes, which kill up to half of long-term users when used exactly as intended, remain legal. Vapes, which the UK’s NHS describes as one of the most effective smoking-cessation tools available, are treated as a drug menace worthy of prison and flogging. The distinction is not health-based; it is cultural and political. Cigarettes are familiar. Vaping is new. Familiar harms are tolerated. Novel ones provoke panic.

What makes Singapore’s crackdown especially dangerous is not just what it does domestically, but how eagerly it has been sanctified by the World Health Organisation. By calling the campaign a “turning point” that will “influence the next decade of global tobacco and drug policy,” the WHO is not merely observing events. It is actively moralising them.

This is moral entrepreneurship in its purest form. The WHO is not acting as a neutral assessor of evidence, weighing trade-offs and unintended consequences. It is acting as a crusading institution that defines deviance, elevates fear into policy, and then rewards governments that enforce its preferred moral order with praise and legitimacy. Severity becomes virtue. Punishment becomes proof of seriousness. Outcomes become secondary.

Moral entrepreneurs do not ask whether policies reduce harm; they ask whether policies send the right message. They do not ask who is pushed back into smoking; they ask whether nicotine use is being sufficiently stigmatised. They do not ask whether prohibition fuels black markets; they ask whether enough symbolic distance has been created between “acceptable” and “unacceptable” behaviour.

In this framework, Singapore’s canings, hotlines, school punishments, and mass surveillance are not excesses. They are features. They demonstrate commitment. They signal purity. And by applauding them, the WHO tells other governments that the path to international approval lies not in pragmatic harm reduction, but in moral absolutism.

This is especially galling given the WHO’s long-standing hostility to tobacco harm reduction. While bodies like the UK’s NHS openly acknowledge vaping as one of the most effective tools for smoking cessation, the WHO continues to insist that vaping has “not been proven effective” at the population level, a claim sustained by selective interpretation, ideological framing, and a near-total disregard for real-world evidence. In practice, this position protects cigarettes, the most lethal consumer product in history, from meaningful competition.

Seen in that light, Singapore’s crackdown is not an aberration. It is the logical endpoint of a moralised approach to nicotine policy, one in which abstinence is the only acceptable outcome and any alternative is treated as a threat rather than a tool. When moral entrepreneurs dominate public health, nuance disappears. Adult agency is sacrificed. Harm reduction is recast as heresy.

Even within Singapore, the façade of total control is cracking. Despite months of crackdowns, vapers report continued access. Cross-border “vape tourism” is already emerging. Enforcement grows ever more labour-intensive and invasive, with diminishing returns. This is the treadmill of prohibition: escalating effort to stand still.

The most revealing voices in the story are not the officials or academics, but the ordinary users caught in the crossfire. Adults who do not use drugs, who did not ask for K-pods, who found vaping a way out of smoking and are now being forced back to the very product public health spent decades trying to reduce. That outcome alone should disqualify Singapore’s approach from being described as a success.

Public health is supposed to be about outcomes, not intentions. About reducing disease and death, not projecting moral certainty. A policy that drives people back to smoking, empowers criminal markets, and relies on corporal punishment to maintain compliance is not a triumph. It is a failure dressed up as resolve.

Singapore has not shown the world how to handle vaping. It has shown what happens when fear, prohibition, and institutional pride override harm reduction. The danger is not that other countries will fail to copy this model. The danger is that they will succeed and repeat the same mistakes, just on a larger scale.